Infliximab does not increase colonic cancer risk associated to murine chronic colitis

Figure 1 Effect of Infliximab on dextran sodium sulphate induced chronic colitis in mice. A: Disease activity index (DAI) in infliximab (IFX) treated animals compared with controls (CT); B: Body weight variation in IFX treated animals compared with CT; C: Colon length at sacrifice in IFX treated mice compared with CT; D: Histology assessment in IFX treated mice compared with CT. ^aP < 0.05, ^bP < 0.01, ^cP < 0.001 vs controls.